A detailed history of Tanager Wealth Management LLP transactions in Eli Lilly & CO stock. As of the latest transaction made, Tanager Wealth Management LLP holds 280 shares of LLY stock, worth $179,440. This represents 0.03% of its overall portfolio holdings.

Number of Shares
280
Previous 314 10.83%
Holding current value
$179,440
Previous $259 Million 15.84%
% of portfolio
0.03%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 18, 2025

SELL
$713.71 - $898.95 $24,266 - $30,564
-34 Reduced 10.83%
280 $218 Million
Q1 2025

Apr 24, 2025

BUY
$725.72 - $929.72 $227,876 - $291,932
314 New
314 $259 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $609B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tanager Wealth Management LLP Portfolio

Follow Tanager Wealth Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tanager Wealth Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Tanager Wealth Management LLP with notifications on news.